Skip to content

Pilot Study: Anti-inflammatory Effect of Peroperative Stimulation of the Vagus Nerve

Pilot Study: Anti-inflammatory Effect of Peroperative Stimulation of the Vagus Nerve: Potential New Therapeutic Intervention to Shorten Postoperative Ileus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01572155
Enrollment
24
Registered
2012-04-06
Start date
2012-03-31
Completion date
2015-12-31
Last updated
2015-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Ileus

Brief summary

Hypothesis: Electrical stimulation of the abdominal vagus nerve has an anti-inflammatory effect and represents a new therapeutic approach to shorten postoperative ileus. Aims: In the present pilot study, the investigators want to evaluate the anti-inflammatory effect of peroperative electrical stimulation of the vagus nerve. To this end, the following aims are formulated: 1. to optimize the technique of intra-operative electrical vagus nerve stimulation 2. to show that electrical stimulation of the intra-abdominal vagus nerve reduces the inflammatory response to abdominal surgery 3. to evaluate whether electrical stimulation of the vagus nerve leads to clinical improvement (collect pilot data)

Interventions

PROCEDUREVagus stimulation 1

2 times 2 minutes (beginning and end of surgery) stimulation at 5 Hz, 500 micro s, 2.5 mA

PROCEDUREVagus stimulation 2

2 times 2 minutes (beginning and end of surgery) stimulation at 20 Hz, 500 micro s, 2.5 mA

Sponsors

Universitaire Ziekenhuizen KU Leuven
CollaboratorOTHER
KU Leuven
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients with rectal carcinoma eligible for open rectal resection * Age between 18 and 70 years

Exclusion criteria

* Preoperative therapeutic abdominal radiation * Evident intra-abdominal inflammation (diagnosed by imaging and/or laboratory test results, including abscess or cholecystitis) * American Society of Anesthesiologists physical-health status classification (ASA-PS) \>3 * Poorly regulated diabetes (\>200 mg/dl (=11mmol/l))

Design outcomes

Primary

MeasureTime frame
levels of pro-inflammatory cytokines in serum, peritoneal lavage and supernatant of stimulated PBMCs (peripheral blood mononuclear cell)From date of surgery until the date of lab analysis (in short time period after taking the blood sample) .Blood samples will be taken before surgery, 2, 24 and 48 hrs after surgery.

Secondary

MeasureTime frame
time to first flatusFrom date of surgery until the date of discharge from the hospital.
time to tolerance of oral food intakeFrom date of surgery until the date of discharge from the hospital
gastric stasis (volume of gastric fluid produced by gastric tube on postoperative day 1)From date of surgery until postoperative day 1.
gastrointestinal symptoms (nausea, pain, bloating)From date of surgery until the date of discharge from the hospital
Time to first defecationFrom date of surgery until the date of discharge from the hospital.
time to tolerance of oral food intake AND first defecationFrom date of surgery until the date of discharge from the hospital

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026